Special Report: Biotechnology Companies & Securities Class Action Litigation (2024)
By EsqSocial Corporation 08/04/25
In 2024, biotechnology companies were the second most targeted industry for securities class action litigation, according to the D&O Databox™, Woodruff Sawyer’s proprietary database of securities class action suits. The plaintiffs’ bar’s playbook is well-known: wait for some bad news, watch the stock price drop, look through previous company statements, and finally file suit alleging that these statements were fraudulently made....
By: Woodruff Sawyer